Skip to content
healthcare.dev

Atovaquone and Proguanil Hydrochloride

NDC 0378-4160, atovaquone and proguanil hydrochloride, tablet, film coated, from Mylan Pharmaceuticals Inc..

Product NDC
0378-4160
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202362
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE62.5 mg/1
  • PROGUANIL HYDROCHLORIDE25 mg/1

Pharmacologic classes

Antimalarial [EPC]; Antimalarial [EPC]; Antiprotozoal [EPC]; Dihydrofolate Reductase Inhibitors [MoA]

Package NDCNDC-11Package
0378-4160-0100378416001100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4160-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57d74d71-8cf8-4b10-9420-22954fae623c
  • NADAC price for package 00378416001

    GET /v1/drugs/nadac/00378416001

Use it

Look up 0378-4160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-4160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.